Medical Gas Market Trends and Opportunities | Therapeutic and Industrial Applications | DataM Intelligence

Medical gas is a specialized category used in various medical applications, including therapeutic, diagnostic, and pharmaceutical. It includes oxygen, nitrous oxide, carbon dioxide, helium, nitrogen, and medical air. Oxygen is used for respiratory support in conditions like COPD and hypoxemia, while nitrous oxide is used as an anaesthetic in surgical procedures. Carbon dioxide is crucial for insufflation during minimally invasive surgeries, and helium is used in respiratory treatments.

According to a report by DataM Intelligence, Global medical gas market reached US$ 18.98 billion in 2024 and is expected to reach US$ 68.31 billion by 2033, growing at a CAGR of 13.6% during the forecast period 2025‑2033.

Key Highlights from the Report:
• Market Size and Growth: The global medical gas market was valued at USD 16.03 billion in 2024 and is projected to reach USD 34.79 billion by 2034, growing at a CAGR of 8.06% from 2025 to 2034.
• Dominance of Pure Gases: The pure gases segment held the largest market share at 56% in 2024, driven by widespread use in respiratory therapies and anesthesia.
• Rapid Growth of Gas Mixtures: The gas mixtures segment is expected to expand at the fastest rate, with a CAGR of 8.32% during the forecast period, reflecting increasing demand for customized therapeutic solutions.
• Therapeutic Applications Lead Demand: Therapeutic applications accounted for more than 41% of the market share in 2024, highlighting the critical role of medical gases in patient care.
• Hospital Sector as Primary End‑User: Hospitals represented the largest end‑user segment, holding 30% of the market share in 2024.

Market Segmentation:
By Product Type – Pure Gases, Gas Mixtures, and Others. Pure gases dominate due to their extensive use in anesthesia, respiratory therapy, and critical care, while gas mixtures are growing rapidly as customized solutions for specialized treatments. The "Others" category includes industrial‑grade gases adapted for medical applications.
By Application – Respiratory Therapy, Cardiovascular Therapy, Anesthesia, Cryosurgery, and Others. Respiratory and anesthesia therapies drive demand, whereas cardiovascular and cryosurgical applications are expanding with advanced medical procedures.
By End‑User – Hospitals & Clinics lead adoption, supported by Ambulatory Surgical Centers (ASCs), reflecting increased procedural volumes and healthcare infrastructure expansion globally.

Regional Insights:
North America – Expected to hold a significant position with the highest market share, fueled by rising respiratory diseases, geriatric populations, and surgical procedures requiring anesthesia gases. Regulatory support and stringent safety standards ensure widespread adoption of medical gas systems in hospitals, ambulatory surgical centres, and research facilities.
Latin America – Brazil and Mexico lead the market, with rising healthcare awareness and modernization of hospital facilities fueling demand for therapeutic gases.
Europe – Germany, France, and the UK dominate Europe's medical gas market, supported by advanced healthcare infrastructure, strong regulatory frameworks, and high adoption of medical gas technologies.
Asia Pacific – China, Japan, and India are the fastest‑growing markets due to increasing healthcare investments, rising prevalence of chronic diseases, and expanding hospital infrastructure.
Middle East and Africa – The UAE, Saudi Arabia, and South Africa are key markets, benefiting from healthcare modernization and adoption of advanced medical technologies, although access remains uneven in some regions.

Market Drivers:
The growth of the pure medical gases market is driven by the increasing prevalence of respiratory diseases like COPD, asthma, and sleep apnea. The demand for high‑purity medical gases is also increasing due to the growing elderly population, pollution levels, industrial emissions, and higher smoking rates. The expansion of healthcare facilities, home care services, and advancements in gas delivery systems are crucial for the widespread adoption of pure medical gases for respiratory treatments.

Market Restraints:
Stringent regulatory requirements for manufacturing, storage, and distribution of medical gases increase compliance costs for manufacturers. High production and operational expenses make it difficult for smaller companies to compete effectively. Supply chain disruptions, including raw material shortages and logistical challenges, can impact timely delivery of medical gases, especially in remote or underdeveloped regions. Additionally, the high cost of advanced medical gases and delivery systems may limit adoption in low‑income countries, restricting market expansion in emerging economies.

Market Opportunities:
Rising prevalence of respiratory and cardiovascular diseases, coupled with an aging population, drives demand for therapeutic gases. Technological advancements in customized gas mixtures and delivery systems create new treatment possibilities. Expansion of hospital infrastructure in emerging regions, increased government support, and rising awareness of medical gas benefits provide strong opportunities for market growth and investment.

Recent Developments:
In January 2025, INOX Air Products, India's largest industrial gases manufacturer, inaugurated the country's first ultra‑high purity electronic grade nitrous oxide plant in Manali, Chennai, with a capacity of 1,700 tonnes per annum, ensuring high purity.
In July 2024, Adenia Partners acquired Air Liquide's operations in 12 African countries, forming Erium, the first pan‑African leader in industrial and medical gases. Erium will replace Air Liquide in Benin, Burkina Faso, Cameroon, Congo, Côte d'Ivoire, Gabon, Ghana, Madagascar, Mali, the Democratic Republic of Congo, Senegal, and Togo.

Conclusion:
The gastric cancer treatment market is poised for substantial growth over the coming years, driven by rising prevalence, increasing awareness, and rapid advancements in targeted therapies and immunotherapies. Strong demand in Asia‑Pacific, particularly in Japan and China, combined with expanding healthcare infrastructure in emerging regions, offers significant growth potential. Innovations such as CAR T‑cell therapy, CLDN18.2‑targeted drugs, and personalized treatment approaches are reshaping the therapeutic landscape, improving patient outcomes and expanding market opportunities.

Contact Us –
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: [email protected]
Phone: +1 877 441 4866
Website:

About Us –
DataM Intelligence is a Market Research and Consulting firm that provides end‑to‑end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in‑depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

Medical Gas Market Trends and Opportunities

DataM Intelligence reports that the global medical gas market grew to roughly USD 17 billion in 2024 and is projected to reach between USD 35 billion by 2034 and USD 68 billion by 2033, depending on the forecast period. The report highlights pure gases as the dominant segment, rapid growth of gas mixtures, and therapeutic applications as the main demand drivers. Key regions include North America, Latin America, Europe, Asia‑Pacific, and the Middle East & Africa. The release also notes recent industry developments such as INOX Air Products’ new nitrous oxide plant and Adenia Partners’ acquisition of Air Liquide’s African operations, forming the pan‑African leader Erium. The article underscores market opportunities driven by respiratory and cardiovascular disease prevalence, aging populations, and technological advances in customized gas mixtures and delivery systems.